Comparable stake leader
AKRE CAPITAL MANAGEMENT LLC
SEC ownership of SOPHiA GENETICS SA
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001840706.
Disclosed value leader
Jurgi Camblong
Comparable rows
31/43
Latest evidence
05 Aug 2026
- Public ticker
- SOPH on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
AKRE CAPITAL MANAGEMENT LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
31 of 43
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
AKRE CAPITAL MANAGEMENT LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
05 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001840706
- Issuer location
- Rolle, Switzerland
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of SOPHiA GENETICS SA (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AKRE CAPITAL MANAGEMENT LLC
Disclosed value leader
Jurgi Camblong
Comparable rows
31/43
Latest evidence
05 Aug 2026
13D/G
3/4/5
13F
Lead comparable stake: 5.6%
12 rows are not safely comparable across share classes.
13D/G row: AKRE CAPITAL MANAGEMENT LLC
Showing 1-8 of 43 holder rows.
Quick read
AKRE CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 5.6%.
31 of 43 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AKRE CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
AKRE CAPITAL MANAGEMENT LLC
5.6%
Balderton Capital VI, S.L.P.
4.9%
Jurgi Camblong
5.2%
Zhenyu Xu
0.88%
AIGH Capital Management LLC
5.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 43 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AKRE CAPITAL MANAGEMENT LLC |
13D/G
|
5.6%
|
$10,673,932
3,719,140 shares
|
$0 | 20 Jun 2025 |
| Balderton Capital VI, S.L.P. |
13D/G
|
4.9%
|
$17,001,386
3,301,240 shares
|
$0 | 31 Dec 2025 |
| Jurgi Camblong |
3/4/5
Executive Chairman, Director
|
5.2%
|
$24,034,011
3,472,822 shares
|
-$2,069,268 | 04 Aug 2026 |
| Zhenyu Xu |
3/4/5
Chief Scientific Officer
|
0.88%
|
$4,417,412
590,887 shares
|
-$411,106 | 05 Aug 2026 |
| AIGH Capital Management LLC |
13F
Company
|
5.9%
|
$22,815,699
3,954,194 shares
|
— | 30 Jun 2026 |
| PRINCIPAL FINANCIAL GROUP INC |
13F
Company
|
3.5%
|
$13,641,756
2,364,256 shares
|
— | 30 Jun 2026 |
| BANQUE PICTET & CIE SA |
13F
Company
|
3.3%
|
$12,741,776
2,208,280 shares
|
— | 30 Jun 2026 |
| Alta Wealth Advisors LLC |
13F
Company
|
2.1%
|
$8,130,853
1,409,160 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$3,212,594.
Buys
$99,000
Insiders: 1
Sells
$3,311,594
Insiders: 10
Net
-$3,212,594
Shares: -580,201
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 20,000
Shares: 600,201
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 20,000 | 376,331 | $99,000 | $2,223,853 | -$2,124,853 |
| 3-6 | 0 | 223,870 | $0 | $1,087,741 | -$1,087,741 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-15 of 15 reporting-owner rows connected to SOPHiA GENETICS SA. Open a relationship link for the CIK-to-CIK filing trail.
Rows
15
Largest Forms 3/4/5 holder
Jurgi Camblong
Net 12M change
-$3,212,594
Latest report
05 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jurgi Camblong | Executive Chairman, Director | $24,034,011 | -$2,069,268 | -7.9% | Filing P/S | 04 Aug 2026 |
| Zhenyu Xu | Chief Scientific Officer | $4,417,412 | -$411,106 | -8.5% | Filing P/S | 05 Aug 2026 |
| Ross Muken | Chief Executive Officer, Director | $3,500,798 | -$166,216 | -4.5% | Filing P/S | 06 Jul 2026 |
| Vincent Ossipow | Director | $2,588,157 | Mixed | 18 Jun 2026 | ||
| George Cardoza | Chief Financial Officer | $1,634,663 | +$51,932 | +3.3% | Filing P/S | 06 Jul 2026 |
| Troy Cox | Director | $1,627,277 | Mixed | 18 Jun 2026 | ||
| Daan van Well | Chief Legal Officer | $1,588,688 | -$69,283 | -4.2% | Filing P/S | 19 May 2026 |
| Abhimanyu Verma | Chief Technology Officer | $1,301,643 | -$117,214 | -8.3% | Filing P/S | 04 Aug 2026 |
| Philippe Menu | Chief Medical Officer | $1,264,616 | -$322,130 | -20% | Filing P/S | 27 Jul 2026 |
| Didier Hirsch | Director | $1,189,089 | Mixed | 18 Jun 2026 | ||
| Manuela Valente | Chief People Officer | $1,063,403 | -$69,664 | -6.1% | Filing P/S | 06 Jul 2026 |
| Jean-Michel Cossery | Director | $1,020,749 | Mixed | 18 Jun 2026 | ||
| Kevin Puylaert | Chief Sales Officer | $752,493 | -$4,608 | -0.61% | Filing P/S | 06 Jul 2026 |
| Kathy L. Hibbs | Director | $541,985 | -$35,037 | -6.1% | Mixed | 18 Jun 2026 |
| Tomer Berkovitz | Director | Mixed | 18 Mar 2026 |
Recent insider transactions for SOPHiA GENETICS SA
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Zhenyu Xu | SOPH | Ordinary Shares | Sale | -2.8% | $123,911 | $7.29 | -17,000 | 590,887 | 07 Aug 2026 | Direct |
| Zhenyu Xu | SOPH | Ordinary Shares | Options Exercise | 1.16% | 7,000 | 607,887 | 07 Aug 2026 | Direct | ||
| Zhenyu Xu | SOPH | Share Option (Right to Buy) | Options Exercise | -100% | -7,000 | 0 | 07 Aug 2026 | Direct | ||
| Zhenyu Xu | SOPH | Ordinary Shares | Sale | -0.5% | $21,013 | $7.00 | -3,000 | 600,887 | 05 Aug 2026 | Direct |
| Zhenyu Xu | SOPH | Ordinary Shares | Options Exercise | 0.5% | 3,000 | 603,887 | 05 Aug 2026 | Direct | ||
| Zhenyu Xu | SOPH | Share Option (Right to Buy) | Options Exercise | -30% | -3,000 | 7,000 | 05 Aug 2026 | Direct | ||
| Abhimanyu Verma | SOPH | Ordinary Shares | Sale | -2.6% | $34,772 | $6.95 | -5,000 | 187,171 | 04 Aug 2026 | Direct |
| Jurgi Camblong | SOPH | Ordinary Shares | Sale | -0.57% | $138,412 | $6.92 | -20,000 | 3,472,822 | 04 Aug 2026 | Direct |
| Zhenyu Xu | SOPH | Ordinary Shares | Sale | -1.64% | $69,168 | $6.92 | -10,000 | 600,887 | 04 Aug 2026 | Direct |
| Philippe Menu | SOPH | Ordinary Shares | Sale | -2.19% | $28,306 | $5.66 | -5,000 | 223,387 | 27 Jul 2026 | Direct |
| Jurgi Camblong | SOPH | Ordinary Shares | Sale | -0.57% | $132,654 | $6.63 | -20,000 | 3,492,822 | 21 Jul 2026 | Direct |
| Jurgi Camblong | SOPH | Ordinary Shares | Options Exercise | 0.13% | 4,581 | 3,517,403 | 20 Jul 2026 | Direct | ||
| Jurgi Camblong | SOPH | Ordinary Shares | Sale | -0.69% | $153,445 | $6.29 | -24,381 | 3,512,822 | 20 Jul 2026 | Direct |
| Jurgi Camblong | SOPH | Share Option (Right to Buy) | Options Exercise | -100% | -4,581 | 0 | 20 Jul 2026 | Direct | ||
| Philippe Menu | SOPH | Ordinary Shares | Sale | -2.14% | $28,505 | $5.70 | -5,000 | 228,387 | 13 Jul 2026 | Direct |
| Zhenyu Xu | SOPH | Ordinary Shares | Sale | -0.65% | $22,819 | $5.70 | -4,000 | 610,887 | 13 Jul 2026 | Direct |
| Jurgi Camblong | SOPH | Ordinary Shares | Sale | -0.24% | $47,791 | $5.62 | -8,500 | 3,532,622 | 10 Jul 2026 | Direct |
| Jurgi Camblong | SOPH | Ordinary Shares | Sale | -0.5% | $93,327 | $5.28 | -17,685 | 3,541,122 | 07 Jul 2026 | Direct |
| George Cardoza | SOPH | Ordinary Shares | Sale | -0.51% | $8,419 | $5.29 | -1,592 | 309,092 | 06 Jul 2026 | Direct |
| Manuela Valente | SOPH | Ordinary Shares | Sale | -1.98% | $21,430 | $5.05 | -4,241 | 210,450 | 06 Jul 2026 | Direct |
| Abhimanyu Verma | SOPH | Ordinary Shares | Sale | -2.68% | $26,957 | $5.10 | -5,285 | 192,171 | 06 Jul 2026 | Direct |
| Zhenyu Xu | SOPH | Ordinary Shares | Sale | -1.19% | $38,242 | $5.17 | -7,393 | 614,887 | 06 Jul 2026 | Direct |
| Ross Muken | SOPH | Ordinary Shares | Sale | -1.45% | $51,354 | $5.22 | -9,838 | 670,651 | 06 Jul 2026 | Direct |
| Kevin Puylaert | SOPH | Ordinary Shares | Sale | -0.15% | $1,087 | $5.03 | -216 | 147,948 | 06 Jul 2026 | Direct |
| Philippe Menu | SOPH | Ordinary Shares | Sale | -3.07% | $38,156 | $5.16 | -7,393 | 233,387 | 06 Jul 2026 | Direct |
| Jurgi Camblong | SOPH | Ordinary Shares | Sale | -0.63% | $118,164 | $5.26 | -22,486 | 3,558,807 | 06 Jul 2026 | Direct |
| Jurgi Camblong | SOPH | Ordinary Shares | Sale | -1.79% | $398,632 | $6.11 | -65,269 | 3,581,293 | 30 Jun 2026 | Direct |
| Jurgi Camblong | SOPH | Ordinary Shares | Options Exercise | 1.26% | 45,419 | 3,646,562 | 30 Jun 2026 | Direct | ||
| Jurgi Camblong | SOPH | Share Option (Right to Buy) | Options Exercise | -90.8% | -45,419 | 4,581 | 30 Jun 2026 | Direct | ||
| Jurgi Camblong | SOPH | Ordinary Shares | Sale | -0.51% | $108,058 | $5.87 | -18,410 | 3,601,143 | 29 Jun 2026 | Direct |
| Jurgi Camblong | SOPH | Ordinary Shares | Options Exercise | 0.5% | 18,060 | 3,619,553 | 29 Jun 2026 | Direct | ||
| Jurgi Camblong | SOPH | Share Option (Right to Buy) | Options Exercise | -26.5% | -18,060 | 50,000 | 29 Jun 2026 | Direct | ||
| Jurgi Camblong | SOPH | Ordinary Shares | Options Exercise | 0.89% | 31,940 | 3,633,433 | 26 Jun 2026 | Direct | ||
| Jurgi Camblong | SOPH | Ordinary Shares | Sale | -1.37% | $290,329 | $5.80 | -50,069 | 3,601,493 | 26 Jun 2026 | Direct |
| Jurgi Camblong | SOPH | Share Option (Right to Buy) | Options Exercise | -31.9% | -31,940 | 68,060 | 26 Jun 2026 | Direct | ||
| Jurgi Camblong | SOPH | Ordinary Shares | Sale | -0.04% | $7,826 | $5.70 | -1,373 | 3,619,622 | 25 Jun 2026 | Direct |
| Abhimanyu Verma | SOPH | Ordinary Shares | Sale | -3.4% | $38,230 | $5.51 | -6,944 | 197,456 | 25 Jun 2026 | Direct |
| Philippe Menu | SOPH | Ordinary Shares | Sale | -2.03% | $27,524 | $5.50 | -5,000 | 240,780 | 25 Jun 2026 | Direct |
| George Cardoza | SOPH | Ordinary Shares | Sale | -0.25% | $4,164 | $5.38 | -774 | 310,684 | 22 Jun 2026 | Direct |
| Ross Muken | SOPH | Ordinary Shares | Sale | -0.06% | $2,270 | $5.38 | -422 | 680,489 | 22 Jun 2026 | Direct |
| Troy Cox | SOPH | Ordinary Shares | Award | 6.38% | 19,724 | 328,743 | 18 Jun 2026 | Direct | ||
| Troy Cox | SOPH | Share Option (Right to Buy) | Award | 12.9% | 28,818 | 252,809 | 18 Jun 2026 | Direct | ||
| Kathy L. Hibbs | SOPH | Ordinary Shares | Award | 22% | 19,724 | 109,492 | 18 Jun 2026 | Direct | ||
| Kathy L. Hibbs | SOPH | Share Option (Right to Buy) | Award | 15.2% | 28,818 | 218,569 | 18 Jun 2026 | Direct | ||
| Vincent Ossipow | SOPH | Ordinary Shares | Award | 3.92% | 19,724 | 522,860 | 18 Jun 2026 | Direct | ||
| Vincent Ossipow | SOPH | Share Option (Right to Buy) | Award | 26.3% | 28,818 | 138,569 | 18 Jun 2026 | Direct | ||
| Jean-Michel Cossery | SOPH | Ordinary Shares | Award | 10.6% | 19,724 | 206,212 | 18 Jun 2026 | Direct | ||
| Jean-Michel Cossery | SOPH | Share Option (Right to Buy) | Award | 26.3% | 28,818 | 138,449 | 18 Jun 2026 | Direct | ||
| Didier Hirsch | SOPH | Ordinary Shares | Award | 8.95% | 19,724 | 240,220 | 18 Jun 2026 | Direct | ||
| Didier Hirsch | SOPH | Share Option (Right to Buy) | Award | 15.2% | 28,818 | 218,569 | 18 Jun 2026 | Direct |
* marks a reported price that did not pass the local price check.